Document Detail


In vitro and in vivo photosensitizing applications of Photofrin in malignant melanoma cells.
MedLine Citation:
PMID:  18782948     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The object of the present study was to evaluate the feasibility of photodynamic therapy (PDT) for malignant melanomas through in vivo and in vitro processes. METHODS: Photofrin (porfimer sodium) was evaluated through in vitro processes with human malignant melanoma cells (MMCs). The in vitro absorption and photosensitizing activity of Photofrin was examined in an MMC culture system. The in vivo biological activity of Photofrin applied to subcutaneous implanted melanoma (SIM) in nude mice and exposed to different total light dosages at 630 nm was studied by determining the destruction of the tumors. Subcelluar localization and binding were observed under a fluorescent confocal microscope. RESULTS: MMCs incubated with Photofrin at a concentration of about 3.5 microg/ml and exposed to laser light at 630 nm with a power density of 100 mW/cm2, showed 50% cell killing. An electron microscopic study demonstrated significant destruction of the target after PDT. CONCLUSION: Detection of the photosensitizer Photofrin was localized and its distribution fully observed. PDT-Photofrin has the capability to destroy MMCs through in vitro and in vivo SIM treatment.
Authors:
Cheng-Jen Chang; Jau-Song Yu; Fu-Chan Wei
Related Documents :
22930628 - Anterior skull base surgery.
23464468 - Overexpression of her-2/neu in malignant mammary tumors; translation of clinicopatholog...
23120578 - Surgical management of parapharyngeal tumors - our experience.
23119668 - Desmoid tumor (aggressive fibromatosis) of the neck.
9657008 - Analysis of loss of heterozygosity in small adenocarcinomas of the lung.
1629928 - Multicentric gastrointestinal and extraintestinal leiomyosarcomatosis: a case report.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Chang Gung medical journal     Volume:  31     ISSN:  2072-0939     ISO Abbreviation:  Chang Gung Med J     Publication Date:    2008 May-Jun
Date Detail:
Created Date:  2008-09-11     Completed Date:  2008-10-16     Revised Date:  2008-12-16    
Medline Journal Info:
Nlm Unique ID:  101088034     Medline TA:  Chang Gung Med J     Country:  China (Republic : 1949- )    
Other Details:
Languages:  eng     Pagination:  260-7     Citation Subset:  IM    
Affiliation:
Department of Plastic Surgery, Chang Gung Memorial Hospital, Taipei, Taiwan, ROC. chengjen@cgmh.org.tw
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Dihematoporphyrin Ether / therapeutic use*
Feasibility Studies
Melanoma / drug therapy*
Mice
Mice, Nude
Photochemotherapy*
Photosensitizing Agents / therapeutic use*
Tumor Cells, Cultured
Chemical
Reg. No./Substance:
0/Photosensitizing Agents; 97067-70-4/Dihematoporphyrin Ether

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of insulin and glucose on cytokine production from peripheral blood mononuclear cells.
Next Document:  Clinical profile and outcome of first acute myocardial infarction with ischemic mitral regurgitation...